Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 410

1.

Primary Ovarian Insufficiency Nationwide Incidence Rate and Etiology Among Israeli Adolescents.

Gruber N, Kugler S, de Vries L, Brener A, Zung A, Eyal O, Rachmiel M, Koren I, Tenenbaum-Rakover Y, Hershkovitz E, Landau Z, Oren M, Eliakim A, Zangen D, German A, Majdoub H, Mazor-Aronovitch K, Modan-Moses D, Yeshayahu Y, Naugolni L, Levy-Shraga Y, Ben-Ami M, Brill G, Zuckerman-Levin N, Levy-Khademi F, Avnon-Ziv C, Tiosano D, Harel S, Kedem E, Segev-Becker A, Shoenfeld Y, Pinhas-Hamiel O.

J Adolesc Health. 2020 Jan 24. pii: S1054-139X(19)30923-1. doi: 10.1016/j.jadohealth.2019.11.315. [Epub ahead of print]

PMID:
31987720
2.

Anthocyanins from Hibiscus syriacus L. Inhibit Melanogenesis by Activating the ERK Signaling Pathway.

Karunarathne WAHM, Molagoda IMN, Park SR, Kim JW, Lee OK, Kwon HY, Oren M, Choi YH, Ryu HW, Oh SR, Jo WS, Lee KT, Kim GY.

Biomolecules. 2019 Oct 24;9(11). pii: E645. doi: 10.3390/biom9110645.

3.

Identifying sources of support and barriers to physical activity in pediatric type 1 diabetes.

Livny R, Said W, Shilo S, Bar-Yoseph R, Gal S, Oren M, Levy M, Weiss R, Shehadeh N, Zuckerman-Levin N, Cohen M.

Pediatr Diabetes. 2020 Feb;21(1):128-134. doi: 10.1111/pedi.12938. Epub 2019 Nov 6.

PMID:
31628818
4.

Flumequine-Mediated Upregulation of p38 MAPK and JNK Results in Melanogenesis in B16F10 Cells and Zebrafish Larvae.

Karunarathne WAHM, Molagoda IMN, Kim MS, Choi YH, Oren M, Park EK, Kim GY.

Biomolecules. 2019 Oct 11;9(10). pii: E596. doi: 10.3390/biom9100596.

5.

p53: not just a tumor suppressor.

Oren M.

J Mol Cell Biol. 2019 Jul 19;11(7):539-543. doi: 10.1093/jmcb/mjz070. No abstract available.

6.

Individual Sea Urchin Coelomocytes Undergo Somatic Immune Gene Diversification.

Oren M, Rosental B, Hawley TS, Kim GY, Agronin J, Reynolds CR, Grayfer L, Smith LC.

Front Immunol. 2019 Jun 6;10:1298. doi: 10.3389/fimmu.2019.01298. eCollection 2019.

7.

Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides.

Tal P, Eizenberger S, Cohen E, Goldfinger N, Pietrokovski S, Oren M, Rotter V.

Oncotarget. 2019 May 7;10(34):3203-3206. doi: 10.18632/oncotarget.26921. eCollection 2019 May 7.

8.

New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?

Shreberk-Shaked M, Oren M.

Mol Oncol. 2019 Jun;13(6):1335-1341. doi: 10.1002/1878-0261.12498. Epub 2019 May 17. Review.

9.

Retraction: Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function.

Weisz L, Zalcenstein A, Stambolsky P, Cohen Y, Goldfinger N, Oren M, Rotter V.

Cancer Res. 2019 Apr 15;79(8):2085. doi: 10.1158/0008-5472.CAN-19-0560. No abstract available.

10.

Usefulness of the 'two-step method' of digital follow-up for early-stage melanoma detection in high-risk French patients: a retrospective 4-year study.

Gasparini G, Madjlessi N, Delyon J, Carmisciano L, Brahimi N, Basset-Seguin N, Oren M, Battistella M, Lebbé C, Herms F, Baroudjian B.

Br J Dermatol. 2019 Aug;181(2):415-416. doi: 10.1111/bjd.18006. Epub 2019 May 12. No abstract available.

PMID:
30977907
11.

Does Decompressive Duraplasty Have a Neuroprotective Effect on Spinal Trauma?: An Experimental Study.

Camlar M, Turk Ç, Buhur A, Oltulu F, Oren M, Senoglu M, Ozer F.

World Neurosurg. 2019 Jun;126:e288-e294. doi: 10.1016/j.wneu.2019.02.043. Epub 2019 Feb 26.

PMID:
30822587
12.

How Safe is the Use of Intrathecal Fluorescein? An Experimental Study.

Camlar M, Turk C, Oltulu F, Oren M, Buhur A, Yigitturk G, Ozer F, Gazioglu N.

Turk Neurosurg. 2019;29(4):549-554. doi: 10.5137/1019-5149.JTN.24085-18.3.

13.

Methods for collection, handling, and analysis of sea urchin coelomocytes.

Smith LC, Hawley TS, Henson JH, Majeske AJ, Oren M, Rosental B.

Methods Cell Biol. 2019;150:357-389. doi: 10.1016/bs.mcb.2018.11.009. Epub 2019 Jan 9. Review.

PMID:
30777184
14.

Mobile Phone-Use Habits Among Adolescents: Predictors of Intensive Use.

Hirsh-Yechezkel G, Mandelzweig L, Novikov I, Bar-Yosef N, Livneh I, Oren M, Waysberg R, Sadetzki S.

Cyberpsychol Behav Soc Netw. 2019 Mar;22(3):212-219. doi: 10.1089/cyber.2018.0177. Epub 2019 Jan 7.

PMID:
30614739
15.

Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.

Shuen AY, Lanni S, Panigrahi GB, Edwards M, Yu L, Campbell BB, Mandel A, Zhang C, Zhukova N, Alharbi M, Bernstein M, Bowers DC, Carroll S, Cole KA, Constantini S, Crooks B, Dvir R, Farah R, Hijiya N, George B, Laetsch TW, Larouche V, Lindhorst S, Luiten RC, Magimairajan V, Mason G, Mason W, Mordechai O, Mushtaq N, Nicholas G, Oren M, Palma L, Pedroza LA, Ramdas J, Samuel D, Wolfe Schneider K, Seeley A, Semotiuk K, Shamvil A, Sumerauer D, Toledano H, Tomboc P, Wierman M, Van Damme A, Lee YY, Zapotocky M, Bouffet E, Durno C, Aronson M, Gallinger S, Foulkes WD, Malkin D, Tabori U, Pearson CE.

J Clin Oncol. 2019 Feb 20;37(6):461-470. doi: 10.1200/JCO.18.00474. Epub 2019 Jan 4.

PMID:
30608896
16.

Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.

Hooda J, Novak M, Salomon MP, Matsuba C, Ramos RI, MacDuffie E, Song M, Hirsch MS, Lester J, Parkash V, Karlan BY, Oren M, Hoon DS, Drapkin R.

Cancer Res. 2019 Feb 15;79(4):760-772. doi: 10.1158/0008-5472.CAN-18-2297. Epub 2018 Dec 18.

17.

Functional characterization of the p53 "mutome".

Kotler E, Segal E, Oren M.

Mol Cell Oncol. 2018 Sep 25;5(6):e1511207. doi: 10.1080/23723556.2018.1511207. eCollection 2018.

18.

LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state.

Furth N, Pateras IS, Rotkopf R, Vlachou V, Rivkin I, Schmitt I, Bakaev D, Gershoni A, Ainbinder E, Leshkowitz D, Johnson RL, Gorgoulis VG, Oren M, Aylon Y.

Life Sci Alliance. 2018 Oct 30;1(5):e201800171. doi: 10.26508/lsa.201800171. eCollection 2018 Oct.

19.

Corrigendum: p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity.

Tovy A, Spiro A, McCarthy R, Shipony Z, Aylon Y, Allton K, Ainbinder E, Furth N, Tanay A, Barton M, Oren M.

Genes Dev. 2018 Oct 1;32(19-20):1358. doi: 10.1101/gad.319863.118. No abstract available.

20.

A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.

Kotler E, Shani O, Goldfeld G, Lotan-Pompan M, Tarcic O, Gershoni A, Hopf TA, Marks DS, Oren M, Segal E.

Mol Cell. 2018 Sep 6;71(5):873. doi: 10.1016/j.molcel.2018.08.013. No abstract available.

Supplemental Content

Loading ...
Support Center